Sort
23,748 grants matching “melanoma”
Development of selective HDAC6 inhibitors to improve cancer immunotherapy
$567,683Alejandro V Villagra · Georgetown University · R01 · FY2024 · CA
Variability of Cellular Responses to Growth Factors and Drugs During Tumorgenesis
$567,651Gregoire Altan-Bonnet · Sloan-Kettering Inst Can Research · U54 · FY2014 · CA
Rewiring Pathways and Networks by Environmental Perturbations
$567,588Marc Vidal · Dana-Farber Cancer Inst · R01 · FY2007 · ES
Mechanism of Activity of Lonidamine
$567,405Jerry D Glickson · University Of Pennsylvania · R01 · FY2013 · CA
Genetic Epidemiology of Melanoma (GenoMel)
$567,359Peter A Kanetsky · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2016 · CA
Comprehensive Sun Protection in Recreation: An Advanced Go Sun Smart Program
$567,241Peter Alex Andersen · San Diego State University · R01 · FY2012 · CA
Impact of AIM2 on Intestinal Stem Cell Differentiation During Inflammation
$567,205Justin Ethan Wilson · University Of Arizona · R01 · FY2025 · DK
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer
$567,204Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2024 · CA
Understanding how adrenergic signaling influences immune contexture of tumors and the efficacy of checkpoint inhibitors
$567,157Elizabeth Repasky · Roswell Park Cancer Institute Corp · R01 · FY2021 · CA
Flow Cytometry
$566,884Michael W Andreeff · University Of Tx Md Anderson Can Ctr · P30 · FY2009 · CA
Development of Organometallic Protein Kinase Inhibitors with Anticancer Activity
$566,873Eric Meggers · Wistar Institute · P01 · FY2011 · CA
A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma.
$566,814James M Markert · University Of Alabama At Birmingham · R01 · FY2017 · CA
Characterization and Functional Analysis of Breast Cancer Secreted Exosomes in Ma
$566,658David Charles Lyden · Weill Medical Coll Of Cornell Univ · U01 · FY2016 · CA
Infections, immunity, and inflammation in cancer
$566,530Eric A Engels · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA
Integrated Tools for Quantitative Whole-Body Tumor Perfusion Imaging
$566,413Gary D Hutchins · Indiana University Indianapolis · R01 · FY2017 · CA
(PQ8) Predicting immune-related toxicity in the adjuvant melanoma setting with checkpoint inhibition
$566,338Iman Osman · New York University School Of Medicine · R01 · FY2020 · CA
Role of circular RNA CDR1as in melanoma
$566,315Eva Hernando · New York University School Of Medicine · R01 · FY2021 · CA
DEVELOPMENTAL ORIGINS AND HOMEOSTATIC MECHANISMS UNDERLYING ADULT PHENOTYPES
$566,220David M Parichy · University Of Virginia · R35 · FY2019 · GM
DEVELOPMENTAL ORIGINS AND HOMEOSTATIC MECHANISMS UNDERLYING ADULT PHENOTYPES
$566,155David M Parichy · University Of Virginia · R35 · FY2018 · GM
Multilevel RCT of Rural Community Sun Safety for Young Children in Sports
$565,996Yelena Ping Wu · Utah State Higher Education System--University Of Utah · R01 · FY2025 · CA
DEVELOPMENTAL ORIGINS AND HOMEOSTATIC MECHANISMS UNDERLYING ADULT PHENOTYPES
$565,989David M Parichy · University Of Virginia · R35 · FY2020 · GM
DEVELOPMENTAL ORIGINS AND HOMEOSTATIC MECHANISMS UNDERLYING ADULT PHENOTYPES
$565,748David M Parichy · University Of Virginia · R35 · FY2021 · GM
Targeting Systems Vulnerabilities in the Gαq/GNAQ Oncogenic Signaling Circuitry: New Precision Therapies for Uveal Melanoma
$565,730J. Silvio Gutkind · University Of California, San Diego · R01 · FY2021 · CA
Technetium and Rhenium in Nuclear Medicine
$565,702Alun Gareth Jones · Harvard Medical School · R01 · FY2007 · CA
ITIM-receptors for cancer treatment
$565,597Chengcheng Zhang · Ut Southwestern Medical Center · R01 · FY2022 · CA